Success Story: NIW Victory After RFE! A Chinese Senior Medical Manager Approved with Our Strategic Guidance

Client’s Testimonial:

“Thank you so much for the incredible service and support throughout my case. I really appreciate the team’s professionalism and efficiency in the whole process. I’m so grateful to work with your team.”

On June 16^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Medical Manager in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Senior Medical Manager

Country of Origin: China

Country of Residence at the Time of Filing: China

Approval Notice Date: June 16^th, 2025

Processing Time: 10 months, 23 days (Premium Processing Upgrade Requested)

Case Summary:

We are proud to share the approval of an I-140 petition under the EB-2 National Interest Waiver (NIW) category for an immunology expert whose innovative work on precision medicine is helping transform the treatment landscape for autoimmune and inflammatory diseases. Although the client received a Request for Evidence (RFE), the case was ultimately approved, testament to the compelling merits of her research and its critical national relevance.

Holding an M.D. and possessing significant experience in both clinical and research settings, the petitioner has dedicated her career to investigating how immune pathways can be targeted to develop novel therapeutics. Her work focuses on identifying genetic variations in immune signaling and using multi-color flow cytometry to evaluate immune cell phenotypes, research that enables more personalized treatment options for rare and severe immune-related conditions. She is currently employed in the pharmaceutical industry and continues to pursue translational research that bridges immunology and precision drug development.

To establish her eligibility for the NIW category, the petition highlighted the following:

The petitioner’s contributions have helped illuminate critical mechanisms in diseases such as systemic lupus erythematosus, Behçet’s disease, and uveitis. Her research on immune receptors, complement components, and non-coding RNAs has influenced studies worldwide, enabling other scientists to develop more effective diagnostic tools and therapeutic strategies for immune disorders.

To further support her petition, two letters of recommendation were submitted by leading experts in the field.

“[Client’s] exemplary record, marked by pioneering research in autoimmune disease pathogenesis, sets her apart as an elite scholar in her field. Her publication portfolio, distinguished by its influence on contemporary immunological paradigms, highlights her standing as an irreplaceable authority in immunology. Her record of transformative advancements has cemented her position at the apex of immunological research.”

We congratulate this client on her successful NIW approval. Through NAILG, we are honored to support driven and accomplished professionals like her, whose work on immunological precision medicine is advancing healthcare innovation and enhancing treatment strategies for some of the most challenging diseases affecting public health.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.